• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.

作者信息

Bhindi Bimal, Boorjian Stephen A

机构信息

Department of Urology, Mayo Clinic, Rochester, MN, USA.

Department of Urology, Mayo Clinic, Rochester, MN, USA.

出版信息

Eur Urol. 2018 Mar;73(3):e70-e71. doi: 10.1016/j.eururo.2017.10.017. Epub 2017 Oct 31.

DOI:10.1016/j.eururo.2017.10.017
PMID:29097100
Abstract
摘要

相似文献

1
Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
Eur Urol. 2018 Mar;73(3):e70-e71. doi: 10.1016/j.eururo.2017.10.017. Epub 2017 Oct 31.
2
Reply to Georgios Papadopoulos, Charalampos Fragkoulis, and Konstantinos Ntoumas' Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
Eur Urol. 2018 Mar;73(3):e53. doi: 10.1016/j.eururo.2017.11.037. Epub 2017 Dec 12.
3
Re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.回复：比马尔·宾迪、伊戈尔·弗兰克、罗斯·J·梅森等。新辅助化疗后膀胱切除术后残留癌患者的肿瘤学结局：一项病理分期匹配分析。《欧洲泌尿外科杂志》2017年；72卷：660 - 664页
Eur Urol. 2018 Mar;73(3):e52. doi: 10.1016/j.eururo.2017.11.036. Epub 2017 Dec 19.
4
Re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.回复：比马尔·宾迪、伊戈尔·弗兰克、罗斯·J·梅森等人。新辅助化疗后膀胱切除术后残留癌患者的肿瘤学结局：一项病理分期匹配分析。《欧洲泌尿外科杂志》2017年；72卷：660 - 664页。
Eur Urol. 2018 Mar;73(3):e69. doi: 10.1016/j.eururo.2017.10.018. Epub 2017 Nov 1.
5
Reply to Samuel Bishara and Jim Adshead's letter to the editor re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45.对塞缪尔·比沙拉和吉姆·阿兹海德致编辑信件的回复，内容涉及：布莱恩·J·林德、伊戈尔·弗兰克、约翰·C·切维尔等人的《围手术期输血对根治性膀胱切除术后癌症复发和生存的影响》。《欧洲泌尿外科杂志》2013年；63卷：839 - 45页
Eur Urol. 2013 Sep;64(3):e49-50. doi: 10.1016/j.eururo.2013.05.058. Epub 2013 Jun 12.
6
Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Eur Urol. 2019 Sep;76(3):e67-e68. doi: 10.1016/j.eururo.2019.05.033. Epub 2019 Jun 2.
7
Response to Claire Vale, David Fisher, Jayne Tierney, Ian White, Matthew Sydes, and James Carpenter's Letter to the Editor re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002.对克莱尔·瓦尔、大卫·费舍尔、杰恩·蒂尔尼、伊恩·怀特、马修·赛兹及詹姆斯·卡彭特致编辑信的回复，信中涉及克里斯托弗·J.D. 沃利斯、扎卡里·克拉斯森、比马尔·宾迪等人的研究：醋酸阿比特龙与多西他赛联合雄激素剥夺疗法治疗高危及转移性初治前列腺癌的比较：一项系统评价和网状荟萃分析。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2017.10.002 。
Eur Urol. 2018 Mar;73(3):e51. doi: 10.1016/j.eururo.2017.11.028. Epub 2017 Dec 8.
8
Re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45.
Eur Urol. 2013 Sep;64(3):e48. doi: 10.1016/j.eururo.2013.05.057. Epub 2013 Jun 7.
9
Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71. Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?
Eur Urol. 2019 May;75(5):e138-e139. doi: 10.1016/j.eururo.2019.01.037. Epub 2019 Feb 1.
10
Re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002.回复：克里斯托弗·J.D.·沃利斯、扎卡里·克拉斯森、比马尔·宾迪等。醋酸阿比特龙和多西他赛与雄激素剥夺疗法治疗高危和转移性初治激素敏感性前列腺癌的比较：一项系统评价和网状Meta分析。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2017.10.002 。
Eur Urol. 2018 Mar;73(3):e49-e50. doi: 10.1016/j.eururo.2017.11.027. Epub 2017 Dec 9.